Vaccine hopes rise as Oxford jab prompts immune response among old and young

Re:Vaccine hopes rise as Oxford jab prompts immune response ... by aphextron on Monday October 26, 2020 @09:53AM (#24896145)

>There is no evidence to prove the vaccine has caused any serious adverse effects so far. If that were the case, it is unlikely the Data Safety and Monitoring Board (DSMB) and U.S. Food and Drug Administration (FDA) would recommend resuming the trial.

There's also no evidence to prove that it wasn't. Furthermore, the AstraZeneca vaccine was halted for a case of transverse myelitis, a very common (and serious) adverse reaction seen in DNA/adenovirus based vaccines like ChAdOx1 [0]. These complications have not been seen at all in the mRNA based vaccines, since they do not involve a live virus.

[0] https://medcitynews.com/2020/10/report-fda-takes-closer-look....

[ Parent | on HN ]

Re:Vaccine hopes rise as Oxford jab prompts immune response ... by RobertDeNiro on Monday October 26, 2020 @10:48AM (#24896718)

Transverse myelitis was also observed in some people infected by sars-cov-2, one case alone is not enough to lead to any meaningful conclusion.

[ Parent | on HN ]

Re:Vaccine hopes rise as Oxford jab prompts immune response ... by MrAlex94 on Monday October 26, 2020 @10:19AM (#24896406)

Well, we won't find out until the trials end, but why would they have been approved to continue by safety boards if that wasn't the case?

Also, the AZ trial was given the go-ahead along with the J&J trial.

https://www.reuters.com/article/us-health-coronavirus-astraz...

[ Parent | on HN ]